| Product Code: ETC9972197 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Opioid Induced Constipation Drugs Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Opioid Induced Constipation Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Opioid Induced Constipation Drugs Market - Industry Life Cycle |
3.4 United States (US) Opioid Induced Constipation Drugs Market - Porter's Five Forces |
3.5 United States (US) Opioid Induced Constipation Drugs Market Revenues & Volume Share, By Active Ingredients, 2021 & 2031F |
3.6 United States (US) Opioid Induced Constipation Drugs Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 United States (US) Opioid Induced Constipation Drugs Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
3.8 United States (US) Opioid Induced Constipation Drugs Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 United States (US) Opioid Induced Constipation Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United States (US) Opioid Induced Constipation Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of opioid use in the United States leading to higher incidences of opioid-induced constipation. |
4.2.2 Growing awareness among healthcare providers about the need for effective treatment options for opioid-induced constipation. |
4.2.3 Continuous research and development efforts to introduce novel drugs with improved efficacy and safety profiles. |
4.3 Market Restraints |
4.3.1 Stringent regulatory environment and increasing scrutiny on opioid medications, leading to limited prescription rates. |
4.3.2 Potential side effects and risks associated with opioid-induced constipation drugs, impacting patient adherence and acceptance. |
5 United States (US) Opioid Induced Constipation Drugs Market Trends |
6 United States (US) Opioid Induced Constipation Drugs Market, By Types |
6.1 United States (US) Opioid Induced Constipation Drugs Market, By Active Ingredients |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Opioid Induced Constipation Drugs Market Revenues & Volume, By Active Ingredients, 2021- 2031F |
6.1.3 United States (US) Opioid Induced Constipation Drugs Market Revenues & Volume, By Naloxegol, 2021- 2031F |
6.1.4 United States (US) Opioid Induced Constipation Drugs Market Revenues & Volume, By Lubiprostone, 2021- 2031F |
6.1.5 United States (US) Opioid Induced Constipation Drugs Market Revenues & Volume, By Methylnaltrexone Bromide, 2021- 2031F |
6.1.6 United States (US) Opioid Induced Constipation Drugs Market Revenues & Volume, By Docusate Sodium, 2021- 2031F |
6.1.7 United States (US) Opioid Induced Constipation Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) Opioid Induced Constipation Drugs Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Opioid Induced Constipation Drugs Market Revenues & Volume, By Over The Counter Medicines, 2021- 2031F |
6.2.3 United States (US) Opioid Induced Constipation Drugs Market Revenues & Volume, By Prescription, 2021- 2031F |
6.2.4 United States (US) Opioid Induced Constipation Drugs Market Revenues & Volume, By Natural Remedies, 2021- 2031F |
6.3 United States (US) Opioid Induced Constipation Drugs Market, By Mode of Administration |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Opioid Induced Constipation Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 United States (US) Opioid Induced Constipation Drugs Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 United States (US) Opioid Induced Constipation Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United States (US) Opioid Induced Constipation Drugs Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Opioid Induced Constipation Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 United States (US) Opioid Induced Constipation Drugs Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 United States (US) Opioid Induced Constipation Drugs Market Revenues & Volume, By Speciality Centres, 2021- 2031F |
6.4.5 United States (US) Opioid Induced Constipation Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United States (US) Opioid Induced Constipation Drugs Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Opioid Induced Constipation Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 United States (US) Opioid Induced Constipation Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 United States (US) Opioid Induced Constipation Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 United States (US) Opioid Induced Constipation Drugs Market Import-Export Trade Statistics |
7.1 United States (US) Opioid Induced Constipation Drugs Market Export to Major Countries |
7.2 United States (US) Opioid Induced Constipation Drugs Market Imports from Major Countries |
8 United States (US) Opioid Induced Constipation Drugs Market Key Performance Indicators |
8.1 Patient-reported outcomes related to symptom relief and quality of life improvements. |
8.2 Number of prescriptions for opioid-induced constipation drugs. |
8.3 Physician adoption rates of new treatment options and guidelines. |
8.4 Patient compliance and persistence rates with prescribed opioid-induced constipation medications. |
8.5 Frequency of adverse events reported with the use of opioid-induced constipation drugs. |
9 United States (US) Opioid Induced Constipation Drugs Market - Opportunity Assessment |
9.1 United States (US) Opioid Induced Constipation Drugs Market Opportunity Assessment, By Active Ingredients, 2021 & 2031F |
9.2 United States (US) Opioid Induced Constipation Drugs Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 United States (US) Opioid Induced Constipation Drugs Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
9.4 United States (US) Opioid Induced Constipation Drugs Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 United States (US) Opioid Induced Constipation Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) Opioid Induced Constipation Drugs Market - Competitive Landscape |
10.1 United States (US) Opioid Induced Constipation Drugs Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Opioid Induced Constipation Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here